多个抗原表位的计算预测
bioRxiv : the preprint server for biology
|August 30, 2024
概括
我们开发了ISPIPab,这是一个新的抗原表位预测工具. ISPIPab集成了多种方法,以提高用于疫苗设计和诊断的标记物识别精度.
科学领域:
- 免疫信息学是指免疫信息学.
- 计算生物学 计算生物学
- 结构生物学 结构生物学
背景情况:
- 对疫苗设计,诊断和药物开发来说,皮层的识别至关重要.
- 实验性表位确定是劳动密集型和昂贵的.
- 目前的计算表位预测工具的准确性有限.
研究的目的:
- 开发一种改进的计算方法,用于抗原表位预测.
- 为了提高医学应用的表位标识的准确性和可靠性.
主要方法:
- ISPIPab集成了两个基于特征的和一个基于对接的预测方法.
- 层次聚类与预测算法相结合.
- 绩效与现有的最先进的方法进行了比较.
主要成果:
- 与单个组成方法相比,ISPIPab显示出更高的性能.
- 该方法的性能优于其他现有的最先进的表位预测工具.
- 层次聚类有助于识别已知的表征物和发现新的表征物.
结论:
- ISPIPab为抗原表位预测提供了更准确,更有效的方法.
- 该工具可以加快免疫诊断试剂和疫苗候选物的发现.
- ISPIPab有助于发现用于进一步实验验证的新型表位标.
更多相关视频
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Antigens Involved in Adaptive Immunity
476
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
476
Diversity of Antigen Receptors
543
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
543
Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K


